Neuroinflammation in cerebral ischemia and ischemia/reperfusion injuries: from pathophysiology to therapeutic strategies

A Jurcau, A Simion - International journal of molecular sciences, 2021 - mdpi.com
Its increasing incidence has led stroke to be the second leading cause of death worldwide.
Despite significant advances in recanalization strategies, patients are still at risk for …

Cell death mechanisms in stroke and novel molecular and cellular treatment options

E Sekerdag, I Solaroglu… - Current …, 2018 - ingentaconnect.com
As a result of ischemia or hemorrhage, blood supply to neurons is disrupted which
subsequently promotes a cascade of pathophysiological responses resulting in cell loss …

Exosome mediated delivery of miR-124 promotes neurogenesis after ischemia

J Yang, X Zhang, X Chen, L Wang, G Yang - Molecular Therapy-Nucleic …, 2017 - cell.com
The intrinsic ability of neurogenesis after stroke has been proven weak, which results in
insufficient repair of injury in the nerve system. Recent studies suggest multiple microRNAs …

The emerging field of epigenetics in neurodegeneration and neuroprotection

JY Hwang, KA Aromolaran, RS Zukin - Nature Reviews Neuroscience, 2017 - nature.com
Epigenetic mechanisms—including DNA methylation, histone post-translational
modifications and changes in nucleosome positioning—regulate gene expression, cellular …

Extracellular vesicles, exosomes and shedding vesicles in regenerative medicine–a new paradigm for tissue repair

IM Bjørge, SY Kim, JF Mano, B Kalionis… - Biomaterials …, 2018 - pubs.rsc.org
Tissue regeneration by stem cells is driven by the paracrine activity of shedding vesicles and
exosomes, which deliver specific cargoes to the recipient cells. Proteins, RNA, cytokines and …

Unraveling the role of miRNAs in the diagnosis, progression, and therapeutic intervention of Alzheimer's disease

NM Abdelmaksoud, AAM Sallam, AI Abulsoud… - … -Research and Practice, 2024 - Elsevier
Alzheimer's disease (AD) is a multifaceted, advancing neurodegenerative illness that is
responsible for most cases of neurological impairment and dementia in the aged population …

A novel microRNA-124/PTPN1 signal pathway mediates synaptic and memory deficits in Alzheimer's disease

X Wang, D Liu, HZ Huang, ZH Wang, TY Hou… - Biological …, 2018 - Elsevier
Background Synaptic loss is an early pathological event in Alzheimer's disease (AD), but its
underlying molecular mechanisms remain largely unknown. Recently, microRNAs (miRNAs) …

MicroRNA-124-3p-enriched small extracellular vesicles as a therapeutic approach for Parkinson's disease

M Esteves, R Abreu, H Fernandes, C Serra-Almeida… - Molecular Therapy, 2022 - cell.com
Parkinson's disease is a neurodegenerative disease characterized by the loss of
dopaminergic neurons in the substantia nigra with no effective cure available. MicroRNA …

An updated role of microRNA-124 in central nervous system disorders: a review

Y Sun, ZM Luo, XM Guo, DF Su, X Liu - Frontiers in cellular …, 2015 - frontiersin.org
MicroRNA-124 (miR-124) is the most abundant miRNA in the brain. Biogenesis of miR-124
displays specific temporal and spatial profiles in various cell and tissue types and affects a …

Neural stem cell differentiation into mature neurons: mechanisms of regulation and biotechnological applications

MS Vieira, AK Santos, R Vasconcellos… - Biotechnology …, 2018 - Elsevier
The abilities of stem cells to self-renew and form different mature cells expand the
possibilities of applications in cell-based therapies such as tissue recomposition in …